Your browser doesn't support javascript.
loading
Show: 20 | 50 | 100
Results 1 - 11 de 11
Filter
Add more filters










Publication year range
1.
Otolaryngol Head Neck Surg ; 152(1): 189-92, 2015 Jan.
Article in English | MEDLINE | ID: mdl-25214549

ABSTRACT

The objective of this study was to evaluate the use of quantum molecular resonance (QMR) energy in phonomicrosurgery. Quantum molecular resonance energy (QMRE) is an innovative technology that provides low temperature cutting and coagulation of tissues and causes minimal tissue damage during the procedure. Because of these features, this technology may offer new possibilities in phonomicrosurgery. Twelve patients with vocal fold polyps underwent QMR-assisted phonomicrosurgery. The patients were evaluated before and after surgery at 1 and 3 months postoperatively by using the voice handicap index, laryngeal stroboscopy rating, acoustic voice analysis, and perceptual voice evaluation. The subjects were also evaluated by a patient self-assessment questionnaire at 3 months postoperatively. All parameters significantly improved after QMR-assisted phonomicrosurgery (P < .05). All of the patients also subjectively improved by self-rating. These results suggest that QMRE is a safe and potentially promising treatment in phonomicrosurgery. Yet, further studies should be conducted to confirm these results.


Subject(s)
Electrocoagulation , Laryngeal Neoplasms/surgery , Microsurgery/methods , Polyps/surgery , Vocal Cords , Adult , Female , Humans , Male , Middle Aged , Otorhinolaryngologic Surgical Procedures/methods , Vibration
2.
Kulak Burun Bogaz Ihtis Derg ; 23(6): 325-30, 2013.
Article in English | MEDLINE | ID: mdl-24283806

ABSTRACT

OBJECTIVES: This study aims to compare histopathological results of conventional surgery and transoral radiofrequency ablation in patients with early stage laryngeal carcinoma. PATIENTS AND METHODS: Between January 2006 and May 2010, 36 patients (34 males, 2 females; mean age 61.6 years; range 43 to 77 years) who underwent partial laryngectomy in our clinic were retrospectively analyzed. All patients were randomized to partial laryngectomy with radiofrequency ablation or conventional surgery. Hoarseness due to early stage T1 and selected T2N0 vocal cord lesions was an indication for surgery. Of 20 patients receiving conventional surgery, 14 underwent partial laryngectomy, while six patients underwent cordectomy for the excision of tumors. Tumors were excised by transoral radiofrequency ablation in 16 patients. RESULTS: We observed thermal artifacts in four patients undergoing conventional surgery and in 13 patients undergoing transoral radiofrequency ablation. There was also hemorrhage in 16 patients undergoing conventional surgery and in seven patients undergoing transoral radiofrequency ablation. Histopathological examination revealed that the surgical margins were safe in 10 patients after radiofrequency ablation. The specimens obtained from six patients showed thermal artifacts which complicated histopathological examination. Sixteen (80%) of 20 conventional surgery patients and nine (56%) of 16 radiofrequency ablation patients had safe surgical margins. CONCLUSION: In radiofrequency ablation, the surgical zone must be larger than in conventional surgery due to the high risk of tissue damage and complicated histopathological examination.


Subject(s)
Laryngeal Neoplasms/surgery , Adult , Aged , Catheter Ablation/methods , Female , Hoarseness , Humans , Laryngeal Neoplasms/pathology , Laryngectomy/methods , Male , Middle Aged , Postoperative Complications , Postoperative Hemorrhage , Treatment Outcome
3.
Kulak Burun Bogaz Ihtis Derg ; 22(4): 245-8, 2012.
Article in English | MEDLINE | ID: mdl-22770263

ABSTRACT

Glomus tumors are uncommon benign neoplasms, which rarely occur in the trachea, usually originating from the posterior wall of the distal portion. Most of tracheal glomus tumors are located in the lower two thirds of the trachea. In this article, we present a 50-year-old male patient with a glomus tumor located on the upper third of the posterior wall of the trachea. A transoral endoscopic laser excision was performed. No finding suggesting tumoral regrowth at 36 months following surgery was found, as assessed by laryngoscopy and imaging studies.


Subject(s)
Glomus Tumor/diagnosis , Tracheal Neoplasms/diagnosis , Diagnosis, Differential , Endoscopy , Glomus Tumor/pathology , Glomus Tumor/surgery , Humans , Laryngoscopy , Laser Therapy , Male , Middle Aged , Tracheal Neoplasms/pathology , Tracheal Neoplasms/surgery
4.
J Med Case Rep ; 6: 147, 2012 Jun 12.
Article in English | MEDLINE | ID: mdl-22691605

ABSTRACT

INTRODUCTION: Teratoma refers to a neoplasm that recapitulates all three germ layers. Teratomas may be histologically mature and oncologically benign. Teratomas may also be histologically immature while being oncologically benign, or they may harbor malignant components and have the potential to exhibit an aggressive biological behavior. Teratomas of the head and neck are extremely rare and usually present in the neonatal period. As a general rule, pediatric teratomas of the head and neck tend to be oncologically benign, whereas adult teratomas tend to be histologically and oncologically malignant. Most of these teratomas are found in the cervical region and nasopharynx. Calcification within the mass is often evident. CASE PRESENTATION: A 27-year-old Caucasian man complaining of a nasal obstruction was admitted to our clinic in January 2006. A transnasal endoscopic examination revealed a mass arising from the nasal septum which was completely removed using an endoscopic approach. Histologically, it was determined to be a benign teratoma. CONCLUSION: Herein, we present a rare case, along with a review of the related literature, in order to emphasize that a benign teratoma of the nasal septum should not be ignored.

5.
Kulak Burun Bogaz Ihtis Derg ; 21(4): 184-91, 2011.
Article in Turkish | MEDLINE | ID: mdl-21762047

ABSTRACT

OBJECTIVES: In this study we aimed to evaluate the quality of life during, before and after septoplasty in patients who were diagnosed with nasal septal deviation and also to demonstrate the role and importance of acoustic rhinometry and rhinomanometry methods in objectively demonstrating surgical success. PATIENTS AND METHODS: This study was carried out in 44 patients undergoing septoplasty surgery. Patients' preoperative complaints were evaluated by Nasal Obstruction Symptom Evaluation (NOSE) scale. The pre- and post-decongestion acoustic rhinometry and rhinomanometry data of the patients were recorded simultaneously. One month after Cottle's septoplasty performed as the septal surgery method, patients were re-evaluated by NOSE scale, acoustic rhinometry and rhinomanometry and the findings were compared with the preoperative data. RESULTS: Compared to the patients' preoperative values, a significant decrease in NOSE scores (p<0.05); a significant increase in the minimal cross-sectional area (MCA1, MCA2) and volume values measured by acoustic rhinometry (p<0.05) and a significant decrease in the nasal resistance values measured by rhinomanometry (p<0.05) were observed. No significant relationship was found between the change in patients' pre- and postoperative NOSE score values and the change in their acoustic rhinometry and rhinomanometry data (p>005). CONCLUSION: Nowadays, evidence-based medical practices are increasingly gaining importance and acoustic rhinometry and rhinomanometry are methods that can be used in objective evaluation of operation success.


Subject(s)
Nasal Septum/abnormalities , Nasal Septum/surgery , Quality of Life , Adolescent , Adult , Female , Humans , Male , Middle Aged , Otorhinolaryngologic Surgical Procedures , Pulmonary Ventilation/physiology , Rhinometry, Acoustic , Rhinoplasty , Treatment Outcome , Young Adult
6.
Kulak Burun Bogaz Ihtis Derg ; 21(4): 215-9, 2011.
Article in Turkish | MEDLINE | ID: mdl-21762052

ABSTRACT

At the histopathologic examination of neck dissection specimens of the patients who underwent surgical treatment with the diagnosis of laryngeal cancer, thyroid cancer metastases may also be detected in addition to laryngeal cancer metastases. Were retrospectively reviewed the files of 74 patients who were diagnosed with laryngeal cancer and underwent total or partial laryngectomy and neck dissection in our clinic between January 2008 and July 2010. Thyroid papillary carcinoma was found in neck dissection specimen of two patients who underwent partial laryngectomy and neck dissection. Total thyroidectomy was performed to complete the treatment. No recurrence or metastasis was found during the postoperative follow-up for an average of 9.5 months (range 5 to 14 months). Although it is a rare condition, the possibility of coexisting thyroid carcinoma in laryngeal cancer patients and the possible need for completion surgery when required should always be kept in mind.


Subject(s)
Carcinoma/diagnosis , Laryngeal Neoplasms/diagnosis , Thyroid Neoplasms/diagnosis , Carcinoma/surgery , Humans , Incidental Findings , Laryngeal Neoplasms/surgery , Male , Middle Aged , Thyroid Neoplasms/surgery
7.
Kulak Burun Bogaz Ihtis Derg ; 21(3): 137-44, 2011.
Article in English | MEDLINE | ID: mdl-21595617

ABSTRACT

OBJECTIVES: In this study we quantified the expression of vascular endothelial growth factor (VEGF) using quantitative real-time polymerase chain reaction in laryngeal squamous cell carcinoma (LSCC) tissues and evaluated the correlation between the level of VEGF and microvessel density (MVD), and clinicopathological factors. PATIENTS AND METHODS: Twenty-seven patients with LSCC undergoing total or partial laryngectomy at the Ear, Nose, and Throat and Head and Neck Surgery Department of the Izmir Tepecik Training and Research Hospital between September 2006 and July 2008. There was no VEGF expression in two patients that were excluded from the study. Twenty-five patients (24 males, 1 female; mean age 61 years; range 43 to 82 years) were included in this study, but MVD levels of 10 patients could not be determined. RESULTS: As defined by the 2003 American Joint Committee on Cancer (AJCC) TNM classification, seven patients (28%) were stage 1, six patients (24%) were stage 2, four patients (16%) were stage 3, and eight patients (32%) were stage 4. Thirteen patients (52%) had well-differentiated (G1) tumors, and twelve had moderately differentiated tumors. Among the 15 patients for whom the MVD was determined, the median value was 48, with a (range 13-78; vessels / 3.76 mm2). Among the 25 patients for whom the VEGF level was determined, the median value was 0.035 vessels / 3.76 mm2 (range 0.010-0.127). CONCLUSION: We could not find a statistical correlation between clinicopathological factors and either VEGF or MVD. Our study demonstrates that VEGF is expressed by LSCC.


Subject(s)
Carcinoma, Squamous Cell/metabolism , Gene Expression Regulation, Neoplastic , Laryngeal Neoplasms/metabolism , Vascular Endothelial Growth Factor A/metabolism , Actins/analysis , Actins/genetics , Adult , Aged , Aged, 80 and over , Carcinoma, Squamous Cell/blood supply , Carcinoma, Squamous Cell/pathology , DNA, Complementary/analysis , DNA, Neoplasm/analysis , Double-Blind Method , Female , Humans , Laryngeal Neoplasms/blood supply , Laryngeal Neoplasms/pathology , Laryngectomy , Lymphatic Metastasis , Male , Microvessels/growth & development , Middle Aged , Neoplasm Staging , Prospective Studies , Real-Time Polymerase Chain Reaction/methods , Turkey , Vascular Endothelial Growth Factor A/genetics
8.
Kulak Burun Bogaz Ihtis Derg ; 19(1): 22-7, 2009.
Article in Turkish | MEDLINE | ID: mdl-19793043

ABSTRACT

OBJECTIVES: To investigate the efficiency of piracetam and acyclovir in treating sudden hearing loss. PATIENTS AND METHODS: Eightyone patients (44 males, 37 females; mean age 40.4 year; range 18 to 72 years) who had treatment between January 2002 and December 2006 with diagnosis of idiopathic sudden hearing loss were evaluated retrospectively. These patients were divided into four groups according to the treatment they received. The patients who had combined treatment constituted the first group; those who had combined treatment and piracetam the second; those who had combined treatment and acyclovir the third; those who had combined treatment, acyclovir, and piracetam the fourth group. RESULTS: For the four treatment groups, in the pre-and post-treatment (10th day) evaluation of the treatment efficiency made by calculation of the hearing thresholds in 250-8000 Hz frequencies, no significant difference between the groups was determined (p>0.05). CONCLUSION: No additional benefit was obtained with acyclovir and piracetam in treatment.


Subject(s)
Acyclovir/therapeutic use , Antiviral Agents/therapeutic use , Hearing Loss, Sensorineural/drug therapy , Hearing Loss, Sudden/drug therapy , Nootropic Agents/therapeutic use , Piracetam/therapeutic use , Adolescent , Adult , Aged , Combined Modality Therapy , Female , Hearing Loss, Sensorineural/therapy , Hearing Loss, Sudden/therapy , Humans , Male , Middle Aged , Neuroprotective Agents/therapeutic use , Retrospective Studies , Treatment Outcome , Young Adult
9.
Cancer Res ; 65(11): 4716-27, 2005 Jun 01.
Article in English | MEDLINE | ID: mdl-15930290

ABSTRACT

Patients suffering from bone metastases of follicular thyroid carcinoma (FTC) have a poor prognosis because of the lack of effective treatment strategies. The overexpression of epidermal growth factor receptor (EGFR) associated with increased vascularity has been implicated in the pathogenesis of FTC and subsequent bone metastases. We hypothesized that inhibiting the phosphorylation of the EGFR and vascular endothelial growth factor receptor (VEGFR) by AEE788, a dual tyrosine kinase inhibitor of EGFR and VEGFR, in combination with paclitaxel would inhibit experimental FTC bone lesions and preserve bone structure. We tested this hypothesis using the human WRO FTC cell line. In culture, AEE788 inhibited the EGF-mediated phosphorylation of EGFR, VEGFR2, mitogen-activated protein kinase, and Akt in culture. AEE788, alone and in combination with paclitaxel, inhibited cell growth and induced apoptosis. When WRO cells were injected into the tibia of nude mice, tumor and endothelial cells within the lesions expressed phosphorylated EGFR, VEGFR, Akt, and mitogen-activated protein kinase that were inhibited by the oral administration of AEE788. Therapy consisting of orally given AEE788 and i.p. injected paclitaxel induced a high level of apoptosis in tumor-associated endothelial cells and tumor cells with the inhibition of tumor growth in the bone and the preservation of bone structure. Collectively, these data show that blocking the phosphorylation of EGFR and VEGFR with AEE788 combined with paclitaxel can significantly inhibit experimental human FTC in the bone of nude mice.


Subject(s)
Bone Neoplasms/prevention & control , Bone Neoplasms/secondary , ErbB Receptors/antagonists & inhibitors , Purines/pharmacology , Receptors, Vascular Endothelial Growth Factor/antagonists & inhibitors , Thyroid Neoplasms/blood supply , Adenocarcinoma, Follicular/blood supply , Adenocarcinoma, Follicular/pathology , Adenocarcinoma, Follicular/prevention & control , Adenocarcinoma, Follicular/secondary , Animals , Antineoplastic Combined Chemotherapy Protocols/pharmacology , Apoptosis/drug effects , Bone Neoplasms/blood supply , Bone Neoplasms/pathology , Cell Proliferation/drug effects , Drug Synergism , ErbB Receptors/biosynthesis , ErbB Receptors/metabolism , Humans , Male , Mice , Mice, Nude , Mitogen-Activated Protein Kinases/antagonists & inhibitors , Mitogen-Activated Protein Kinases/biosynthesis , Mitogen-Activated Protein Kinases/metabolism , Neovascularization, Pathologic/drug therapy , Neovascularization, Pathologic/metabolism , Paclitaxel/administration & dosage , Paclitaxel/pharmacology , Phosphorylation/drug effects , Polymerase Chain Reaction , Protein Serine-Threonine Kinases/antagonists & inhibitors , Protein Serine-Threonine Kinases/biosynthesis , Protein Serine-Threonine Kinases/metabolism , Proto-Oncogene Proteins/antagonists & inhibitors , Proto-Oncogene Proteins/biosynthesis , Proto-Oncogene Proteins/metabolism , Proto-Oncogene Proteins c-akt , Purines/administration & dosage , Receptors, Vascular Endothelial Growth Factor/metabolism , Thyroid Neoplasms/drug therapy , Thyroid Neoplasms/metabolism , Thyroid Neoplasms/pathology , Vascular Endothelial Growth Factor Receptor-2/antagonists & inhibitors , Vascular Endothelial Growth Factor Receptor-2/biosynthesis , Vascular Endothelial Growth Factor Receptor-2/metabolism
10.
Int J Pediatr Otorhinolaryngol ; 68(10): 1333-7, 2004 Oct.
Article in English | MEDLINE | ID: mdl-15364506

ABSTRACT

A primary alveolar soft part sarcoma arising in the nasal-paranasal sinuses region is quite rare. In this report, a 14-year-old boy with typical features of alveolar soft part sarcoma of the nasal and paranasal sinuses is presented. Treatment was surgical excision of the mass combined with radiotherapy. There has been no recurrence or metastasis as of 2 years after treatment.


Subject(s)
Paranasal Sinus Neoplasms/pathology , Paranasal Sinuses/surgery , Sarcoma/pathology , Adolescent , Disease-Free Survival , Humans , Immunohistochemistry , Male , Paranasal Sinus Neoplasms/surgery , Sarcoma/surgery , Tomography, X-Ray Computed , Treatment Outcome
11.
Am J Otolaryngol ; 23(5): 293-6, 2002.
Article in English | MEDLINE | ID: mdl-12239696

ABSTRACT

A 63-year-old man presented with malignant fibrous histiocytoma of the larynx occurring 16 years after radiation treatment for squamous cell carcinoma of the larynx. Postirradiation sarcoma of the larynx is an unusual tumor. The location, the histopathologic and immunohistochemical appearance of the tumor, and the time elapsed since the initial treatment make it probable that this tumor is associated with prior radiation treatment. The possibility of postirradiation sarcomas after radiation therapy should not be a major factor influencing treatment decisions in the patients with head and neck cancer. Wide surgical resection of the tumor seems to be an efficient means in the management of this tumor.


Subject(s)
Carcinoma, Squamous Cell/radiotherapy , Histiocytoma, Benign Fibrous/etiology , Laryngeal Neoplasms/etiology , Laryngeal Neoplasms/radiotherapy , Low-Level Light Therapy/adverse effects , Carcinoma, Squamous Cell/pathology , Histiocytoma, Benign Fibrous/pathology , Humans , Laryngeal Neoplasms/pathology , Male , Middle Aged
SELECTION OF CITATIONS
SEARCH DETAIL
...